Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor
Navigation Menu

Type of lung cancer-Non-small cell lung carcinoma (NSCLC) Posts on Medivizor

Is combined treatment with erlotinib and bevacizumab effective in non-small cell lung cancer?

Posted by on May 18, 2019 in Lung cancer | 0 comments

In a nutshell This study investigated the effectiveness of erlotinib (Tarceva) and bevacizumab (Avastin) compared ti erlotinib alone in non-small cell lung cancer (NSCLC). They found that combined treatment improved survival after 12 months. Some background Non-small cell lung cancer (NSCLC) is a common type of lung cancer (LC)....

Read More

Evaluating crizotinib for patients with non-small cell lung cancer that has spread to the brain

Posted by on May 4, 2019 in Lung cancer | 0 comments

In a nutshell This study evaluated how well crizotinib (Xalkori) works in patients with non-small cell lung cancer (NSCLC) with an ALK mutation that had spread to the brain. This study found that crizotinib treatment improved survival, but not for patients with cancer in the brain that continued to grow. Some background NSCLC is the most common type...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More

SBRT vs. radiotherapy in patients with inoperable non-small cell lung cancer

Posted by on Mar 5, 2019 in Lung cancer | 0 comments

In a nutshell This study determined whether stereotactic body radiation therapy (SBRT) was more effective than standard radiotherapy in patients with inoperable non-small cell lung cancer. The study found that SBRT led to better survival outcomes for these patients, with minimal side effects. Some background Tumor removal by surgery is the standard of...

Read More

Effects on survival: thermal ablation vs stereotactic radiation therapy for non-small cell lung cancer

Posted by on Jan 20, 2019 in Lung cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of thermal ablation (TA) compared to stereotactic radiation therapy (SRT) for the treatment of non-small-cell lung cancer (NSCLC). The authors concluded that both thermal ablation and stereotactic radiation are safe and can improve survival of these patients. Some...

Read More

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out if the medication brigatinib (Alunbrig) is better than crizotinib (Xalkori) in treating patients with lung cancer. The study found that survival was significantly longer in patients who were treated with brigatinib compared to those treated with crizotinib. Some background Brigatinib and crizotinib are a...

Read More

Alectinib vs crizotinib in treating brain or spinal cord tumors in patients with non-small cell lung cancer

Posted by on Jan 12, 2019 in Lung cancer | 0 comments

In a nutshell This study wanted to find out which medication is better for treating lung cancer that has spread to the brain or spinal cord, crizotinib (Xalkori) or alectinib (Alecensa). The study found that alectinib worked better than crizotinib for treatment of tumors of the brain and spinal cord. Some background Alectinib and crizotinib are two...

Read More